Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
38
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Johnston Walt | See Remarks | 5 | $0 | $0 | 2021-03-29 |
| Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | 10 | $0 | $0 | 2021-03-29 |
| Kurstjens Sef | Director | 11 | $0 | $0 | 2021-03-29 |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | 14 | $0 | $0 | 2021-03-29 |
| Robinson James A. Jr. | PEO;CEO/Urovant Sciences, Inc. | 9 | $0 | $0 | 2021-03-29 |
| Hindman James M. | Director | 6 | $0 | $0 | 2021-03-29 |
| Legault Pierre | Director | 11 | $0 | $0 | 2021-03-29 |
| OCAMPO CHRISTINE | PFAO;CAO/Urovant Sciences,Inc. | 9 | $0 | $0 | 2021-03-29 |
| BANSAL AJAY | See Remarks | 6 | $0 | $0 | 2021-03-29 |
| POTTER MYRTLE S | Director | 10 | $0 | $0 | 2021-03-29 |
| Sumitovant Biopharma Ltd. | 10% Owner | 3 | $1.35M | $0 | 2020-02-19 |
| Katkin Keith | PEO;CEO/Urovant Sciences, Inc. | 12 | $0 | $1.53M | 2020-02-19 |
| Roivant Sciences Ltd. | 10% Owner | 28 | $38.75M | $0 | 2019-12-27 |
| Torti Frank | Director | 2 | $0 | $0 | 2019-07-09 |
| QVT Financial Investment Cayman Ltd. | 10% Owner | 9 | $427.8K | $0 | 2019-06-19 |
| Dexcel Pharma Technologies Ltd. | 10% Owner | 19 | $38.39M | $0 | 2019-06-19 |
| SoftBank Vision Fund L.P. | 10% Owner | 10 | $37.92M | $0 | 2019-06-19 |
| Lo Andrew | 10% Owner | 27 | $38.75M | $0 | 2019-06-19 |
| VGE III Portfolio Ltd. | 10% Owner | 7 | $37.76M | $0 | 2019-06-19 |
| Machado Patrick | 10% Owner | 27 | $38.75M | $0 | 2019-06-19 |
| HALVORSEN OLE ANDREAS | 10% Owner | 11 | $37.98M | $0 | 2019-06-19 |
| SVF Holdings (UK) LLP | 10% Owner | 6 | $354.6K | $0 | 2019-06-14 |
| Shabet Rose Sharon | 10% Owner | 3 | $177.3K | $0 | 2019-06-14 |
| QVT Associates GP LLC | 10% Owner | 17 | $819.4K | $0 | 2019-06-14 |
| Viking Global Equities LP | 10% Owner | 3 | $177.3K | $0 | 2019-06-14 |
| Viking Global Opportunities Portfolio GP LLC | 10% Owner | 3 | $177.3K | $0 | 2019-06-11 |
| Viking Long Fund GP LLC | 10% Owner | 3 | $177.3K | $0 | 2019-06-11 |
| SVF GP (Jersey) Ltd | 10% Owner | 3 | $166.0K | $0 | 2019-06-06 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% Owner | 7 | $328.9K | $0 | 2019-06-06 |
| VIKING GLOBAL PERFORMANCE LLC | 10% Owner | 3 | $166.0K | $0 | 2019-06-06 |
| Viking Global Equities Master Ltd. | 10% Owner | 4 | $138.9K | $0 | 2019-06-03 |
| SVF Investments (UK) Ltd | 10% Owner | 8 | $301.8K | $0 | 2019-06-03 |
| VIKING GLOBAL INVESTORS LP | 10% Owner | 7 | $249.4K | $0 | 2019-06-03 |
| Dexxon Holdings Ltd. | 10% Owner | 8 | $355.8K | $0 | 2019-05-29 |
| Ott David C. | 10% Owner | 3 | $99.98M | $0 | 2019-05-23 |
| McFadden Michael E. | CCO/Urovant Sciences, Inc. | 2 | $0 | $0 | 2019-01-06 |
| Ebersole Nori | SVP;CHRO/Urovant Sciences, Inc | 2 | $0 | $0 | 2019-01-06 |
| QVT Fund V LP | 10% Owner | 1 | $37.50M | $0 | 2018-10-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| POTTER MYRTLE S | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 50,000 | — | $0 | 0 | SEC↗ |
| POTTER MYRTLE S | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 25,000 | — | $0 | 0 | SEC↗ |
| POTTER MYRTLE S | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 15,000 | — | $0 | 0 | SEC↗ |
| OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,In | D To issuer deriv | 2021-03-29 | 2021-03-31 | 3,750 | — | $0 | 0 | SEC↗ |
| OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,In | D To issuer deriv | 2021-03-29 | 2021-03-31 | 133,500 | — | $0 | 0 | SEC↗ |
| OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,In | D To issuer deriv | 2021-03-29 | 2021-03-31 | 70,000 | — | $0 | 0 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 93,450 | — | $0 | 0 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 20,000 | — | $0 | 0 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 3,500 | — | $0 | 0 | SEC↗ |
| BANSAL AJAY | See Remarks | D To issuer deriv | 2021-03-29 | 2021-03-31 | 140,000 | — | $0 | 0 | SEC↗ |
| Hindman James M. | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 61,000 | — | $0 | 0 | SEC↗ |
| Hindman James M. | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 15,000 | — | $0 | 0 | SEC↗ |
| Johnston Walt | See Remarks | D To issuer deriv | 2021-03-29 | 2021-03-31 | 69,197 | — | $0 | 0 | SEC↗ |
| Kurstjens Sef | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 13,350 | — | $0 | 0 | SEC↗ |
| Kurstjens Sef | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 36,650 | — | $0 | 0 | SEC↗ |
| Kurstjens Sef | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 15,000 | — | $0 | 0 | SEC↗ |
| Kurstjens Sef | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 25,000 | — | $0 | 0 | SEC↗ |
| Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 146,850 | — | $0 | 0 | SEC↗ |
| Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 100,000 | — | $0 | 0 | SEC↗ |
| Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 1,000 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 25,000 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 15,000 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 36,650 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | D To issuer deriv | 2021-03-29 | 2021-03-31 | 13,350 | — | $0 | 0 | SEC↗ |
| Robinson James A. Jr. | PEO;CEO/Urovant Sciences, In | D To issuer deriv | 2021-03-29 | 2021-03-31 | 845,732 | — | $0 | 0 | SEC↗ |
| Robinson James A. Jr. | PEO;CEO/Urovant Sciences, In | D To issuer deriv | 2021-03-29 | 2021-03-31 | 50,000 | — | $0 | 0 | SEC↗ |
| Robinson James A. Jr. | PEO;CEO/Urovant Sciences, In | D To issuer deriv | 2021-03-29 | 2021-03-31 | 25,000 | — | $0 | 0 | SEC↗ |
| POTTER MYRTLE S | Director | D To issuer | 2021-03-29 | 2021-03-31 | 12,480 | — | $0 | 0 | SEC↗ |
| POTTER MYRTLE S | Director | D To issuer | 2021-03-29 | 2021-03-31 | 9,000 | — | $0 | 0 | SEC↗ |
| OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,In | D To issuer | 2021-03-29 | 2021-03-31 | 9,810 | — | $0 | 0 | SEC↗ |
| OCAMPO CHRISTINE | PAO; CAO/Urovant Sciences,In | D To issuer | 2021-03-29 | 2021-03-31 | 68,971 | — | $0 | 0 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | D To issuer | 2021-03-29 | 2021-03-31 | 9,341 | — | $0 | 0 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | D To issuer | 2021-03-29 | 2021-03-31 | 115,106 | — | $0 | 0 | SEC↗ |
| BANSAL AJAY | See Remarks | D To issuer | 2021-03-29 | 2021-03-31 | 115,222 | — | $0 | 0 | SEC↗ |
| BANSAL AJAY | See Remarks | D To issuer | 2021-03-29 | 2021-03-31 | 24,876 | — | $0 | 0 | SEC↗ |
| Hindman James M. | Director | D To issuer | 2021-03-29 | 2021-03-31 | 9,000 | — | $0 | 0 | SEC↗ |
| Johnston Walt | See Remarks | D To issuer | 2021-03-29 | 2021-03-31 | 492 | — | $0 | 0 | SEC↗ |
| Johnston Walt | See Remarks | D To issuer | 2021-03-29 | 2021-03-31 | 108,647 | — | $0 | 0 | SEC↗ |
| Kurstjens Sef | Director | D To issuer | 2021-03-29 | 2021-03-31 | 12,480 | — | $0 | 0 | SEC↗ |
| Kurstjens Sef | Director | D To issuer | 2021-03-29 | 2021-03-31 | 9,000 | — | $0 | 0 | SEC↗ |
| Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | D To issuer | 2021-03-29 | 2021-03-31 | 129,745 | — | $0 | 0 | SEC↗ |
| Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | D To issuer | 2021-03-29 | 2021-03-31 | 11,603 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | D To issuer | 2021-03-29 | 2021-03-31 | 9,000 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | D To issuer | 2021-03-29 | 2021-03-31 | 12,480 | — | $0 | 0 | SEC↗ |
| Robinson James A. Jr. | PEO;CEO/Urovant Sciences, In | D To issuer | 2021-03-29 | 2021-03-31 | 8,385 | — | $0 | 0 | SEC↗ |
| Robinson James A. Jr. | PEO; CEO/Urovant Sciences, I | F Tax w/h | 2021-01-10 | 2021-01-12 | 4,095 | $16.11 | $66.0K | 8,385 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | F Tax w/h | 2021-01-07 | 2021-01-08 | 4,761 | $16.09 | $76.6K | 124,447 | SEC↗ |
| Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | F Tax w/h | 2021-01-07 | 2021-01-08 | 5,810 | $16.09 | $93.5K | 141,348 | SEC↗ |
| Kurstjens Sef | Director | A Award deriv | 2020-07-21 | 2020-07-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| POTTER MYRTLE S | Director | A Award deriv | 2020-07-21 | 2020-07-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Legault Pierre | Director | A Award deriv | 2020-07-21 | 2020-07-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hindman James M. | Director | A Award deriv | 2020-07-21 | 2020-07-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kurstjens Sef | Director | A Award | 2020-07-21 | 2020-07-23 | 9,000 | — | $0 | 21,480 | SEC↗ |
| POTTER MYRTLE S | Director | A Award | 2020-07-21 | 2020-07-23 | 9,000 | — | $0 | 21,480 | SEC↗ |
| Legault Pierre | Director | A Award | 2020-07-21 | 2020-07-23 | 9,000 | — | $0 | 21,480 | SEC↗ |
| Hindman James M. | Director | A Award | 2020-07-21 | 2020-07-23 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Johnston Walt | SVP, Commercial, USI | A Award deriv | 2020-06-02 | 2020-06-03 | 69,197 | — | $0 | 69,197 | SEC↗ |
| Johnston Walt | SVP, Commercial, USI | A Award | 2020-06-02 | 2020-06-03 | 108,647 | — | $0 | 108,647 | SEC↗ |
| Hindman James M. | Director | A Award deriv | 2020-06-01 | 2020-06-01 | 61,000 | — | $0 | 61,000 | SEC↗ |
| BANSAL AJAY | PFO;CFO/Urovant Sciences, In | A Award | 2020-05-01 | 2020-05-04 | 63,659 | — | $0 | 138,659 | SEC↗ |
| OCAMPO CHRISTINE | PAO;CAO/Urovant Sciences, In | A Award | 2020-05-01 | 2020-05-04 | 44,346 | — | $0 | 77,179 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | A Award | 2020-05-01 | 2020-05-04 | 77,606 | — | $0 | 127,606 | SEC↗ |
| Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | A Award | 2020-05-01 | 2020-05-04 | 83,149 | — | $0 | 145,277 | SEC↗ |
| Robinson James A. Jr. | PEO;CEO/Urovant Sciences, In | A Award deriv | 2020-03-23 | 2020-03-25 | 845,732 | — | $0 | 845,732 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | M Exercise deriv | 2020-02-19 | 2020-02-21 | 50,000 | — | $0 | 20,000 | SEC↗ |
| Katkin Keith | PEO;CEO/Urovant Sciences, In | M Exercise deriv | 2020-02-19 | 2020-02-21 | 180,000 | — | $0 | 701,254 | SEC↗ |
| Sumitovant Biopharma Ltd. | 10% Owner | P Buy | 2020-02-19 | 2020-02-21 | 75,212 | $13.08 | $983.8K | 22,963,263 | SEC↗ |
| Sumitovant Biopharma Ltd. | 10% Owner | P Buy | 2020-02-19 | 2020-02-21 | 12,873 | $13.08 | $168.4K | 22,872,886 | SEC↗ |
| Sumitovant Biopharma Ltd. | 10% Owner | P Buy | 2020-02-19 | 2020-02-21 | 15,165 | $13.08 | $198.4K | 22,888,051 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | J Other | 2020-02-19 | 2020-02-21 | 15,165 | $13.08 | $198.4K | 50,000 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | F Tax w/h | 2020-02-19 | 2020-02-21 | 34,835 | $13.08 | $455.6K | 65,165 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | M Exercise | 2020-02-19 | 2020-02-21 | 50,000 | $6.88 | $344.0K | 100,000 | SEC↗ |
| Katkin Keith | PEO;CEO/Urovant Sciences, In | J Other | 2020-02-19 | 2020-02-21 | 75,212 | $13.08 | $983.8K | 199,680 | SEC↗ |
| Katkin Keith | PEO;CEO/Urovant Sciences, In | F Tax w/h | 2020-02-19 | 2020-02-21 | 104,788 | $13.08 | $1.37M | 274,892 | SEC↗ |
| Katkin Keith | PEO;CEO/Urovant Sciences, In | M Exercise | 2020-02-19 | 2020-02-21 | 180,000 | $3.86 | $694.8K | 379,680 | SEC↗ |
| Kurstjens Sef | Director | A Award | 2020-01-10 | 2020-01-14 | 12,480 | — | $0 | 12,480 | SEC↗ |
| Legault Pierre | Director | A Award | 2020-01-10 | 2020-01-14 | 12,480 | — | $0 | 12,480 | SEC↗ |
| POTTER MYRTLE S | Director | A Award | 2020-01-10 | 2020-01-14 | 12,480 | — | $0 | 12,480 | SEC↗ |
| Robinson James A. Jr. | Director | A Award | 2020-01-10 | 2020-01-14 | 12,480 | — | $0 | 12,480 | SEC↗ |
| Smith Bryan E. | GC/Urovant Sciences, Inc. | A Award | 2020-01-07 | 2020-01-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OCAMPO CHRISTINE | PAO;CAO/Urovant Sciences, In | A Award | 2020-01-07 | 2020-01-09 | 32,833 | — | $0 | 32,833 | SEC↗ |
| Haag-Molkenteller Cornelia | CMO/Urovant Sciences, Inc. | A Award | 2020-01-07 | 2020-01-09 | 62,128 | — | $0 | 62,128 | SEC↗ |
| Katkin Keith | PEO;CEO/Urovant Sciences, In | A Award | 2020-01-07 | 2020-01-09 | 199,680 | — | $0 | 199,680 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | S Sale | 2019-12-27 | 2019-12-31 | 22,860,013 | — | $0 | 0 | SEC↗ |
| Katkin Keith | PEO;CEO/Urovant Sciences, In | M Exercise deriv | 2019-12-09 | 2019-12-11 | 120,000 | — | $0 | 881,254 | SEC↗ |
| Katkin Keith | PEO;CEO/Urovant Sciences, In | M Exercise | 2019-12-09 | 2019-12-11 | 120,000 | $3.86 | $463.2K | 120,000 | SEC↗ |
| Katkin Keith | PEO;CEO/Urovant Sciences, In | S Sale | 2019-12-09 | 2019-12-11 | 120,000 | $12.78 | $1.53M | 0 | SEC↗ |
| BANSAL AJAY | PFO;CFO/Urovant Sciences, In | A Award deriv | 2019-11-05 | 2019-11-05 | 140,000 | — | $0 | 140,000 | SEC↗ |
| BANSAL AJAY | PFO;CFO/Urovant Sciences, In | A Award | 2019-11-05 | 2019-11-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kurstjens Sef | Director | A Award deriv | 2019-07-09 | 2019-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Legault Pierre | Director | A Award deriv | 2019-07-09 | 2019-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| POTTER MYRTLE S | Director | A Award deriv | 2019-07-09 | 2019-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Robinson James A. Jr. | Director | A Award deriv | 2019-07-09 | 2019-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Torti Frank | Director | A Award deriv | 2019-07-09 | 2019-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| HALVORSEN OLE ANDREAS | 10% Owner | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| VGE III Portfolio Ltd. | 10% Owner | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| SoftBank Vision Fund L.P. | 10% Owner | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| QVT Financial Investment Cayma | 10% Owner | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| HALVORSEN OLE ANDREAS | 10% Owner | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| VGE III Portfolio Ltd. | 10% Owner | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| SoftBank Vision Fund L.P. | 10% Owner | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| QVT Financial Investment Cayma | 10% Owner | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| HALVORSEN OLE ANDREAS | 10% Owner | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| VGE III Portfolio Ltd. | 10% Owner | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| SoftBank Vision Fund L.P. | 10% Owner | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| QVT Financial Investment Cayma | 10% Owner | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| Shabet Rose Sharon | 10% Owner | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| Viking Global Equities LP | 10% Owner | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| SVF Holdings (UK) LLP | 10% Owner | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| Shabet Rose Sharon | 10% Owner | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| Viking Global Equities LP | 10% Owner | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| SVF Holdings (UK) LLP | 10% Owner | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| Shabet Rose Sharon | 10% Owner | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| Viking Global Equities LP | 10% Owner | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| SVF Holdings (UK) LLP | 10% Owner | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| Viking Long Fund GP LLC | 10% Owner | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| Viking Global Opportunities Po | 10% Owner | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| SVF Holdings (UK) LLP | 10% Owner | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| Viking Long Fund GP LLC | 10% Owner | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| Viking Global Opportunities Po | 10% Owner | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| SVF Holdings (UK) LLP | 10% Owner | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| Viking Long Fund GP LLC | 10% Owner | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| Viking Global Opportunities Po | 10% Owner | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| SVF Holdings (UK) LLP | 10% Owner | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| VIKING GLOBAL PERFORMANCE LLC | 10% Owner | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| SVF GP (Jersey) Ltd | 10% Owner | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| QVT Financial Investment Cayma | 10% Owner | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| VIKING GLOBAL PERFORMANCE LLC | 10% Owner | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| SVF GP (Jersey) Ltd | 10% Owner | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| QVT Financial Investment Cayma | 10% Owner | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| VIKING GLOBAL PERFORMANCE LLC | 10% Owner | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| SVF GP (Jersey) Ltd | 10% Owner | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| QVT Financial Investment Cayma | 10% Owner | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| Viking Global Equities Master | 10% Owner | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| SVF Investments (UK) Ltd | 10% Owner | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| Viking Global Equities Master | 10% Owner | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| SVF Investments (UK) Ltd | 10% Owner | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| Viking Global Equities Master | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| Viking Global Equities Master | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| SVF Investments (UK) Ltd | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| SVF Investments (UK) Ltd | 10% Owner | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| QVT Financial Investment Cayma | 10% Owner | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| VGE III Portfolio Ltd. | 10% Owner | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| Dexxon Holdings Ltd. | 10% Owner | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| SoftBank Vision Fund L.P. | 10% Owner | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| QVT Financial Investment Cayma | 10% Owner | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| VGE III Portfolio Ltd. | 10% Owner | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| Dexxon Holdings Ltd. | 10% Owner | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| SoftBank Vision Fund L.P. | 10% Owner | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,732,710 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| QVT Financial Investment Cayma | 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| VGE III Portfolio Ltd. | 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| Dexxon Holdings Ltd. | 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| SoftBank Vision Fund L.P. | 10% Owner | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| HALVORSEN OLE ANDREAS | 10% Owner | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| Ott David C. | 10% Owner | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 0 | SEC↗ |
| SoftBank Vision Fund L.P. | 10% Owner | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| Dexxon Holdings Ltd. | 10% Owner | P Buy | 2019-05-23 | 2019-05-28 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| HALVORSEN OLE ANDREAS | 10% Owner | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| Ott David C. | 10% Owner | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| SoftBank Vision Fund L.P. | 10% Owner | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| Dexxon Holdings Ltd. | 10% Owner | P Buy | 2019-05-22 | 2019-05-28 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| Dexxon Holdings Ltd. | 10% Owner | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| HALVORSEN OLE ANDREAS | 10% Owner | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| Ott David C. | 10% Owner | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $9995.00 | $99.90M | 22,735,272 | SEC↗ |
| SoftBank Vision Fund L.P. | 10% Owner | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 22,725,277 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 22,723,562 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 22,723,562 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 22,725,277 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 22,723,562 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 22,725,277 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 22,725,277 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 22,723,562 | SEC↗ |
| SVF Investments (UK) Ltd | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 22,723,562 | SEC↗ |
| SVF Investments (UK) Ltd | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 1,714 | $8.39 | $14.4K | 22,725,277 | SEC↗ |
| HALVORSEN OLE ANDREAS | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 0 | SEC↗ |
| HALVORSEN OLE ANDREAS | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 0 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 0 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 0 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-05-20 | 2019-05-22 | 1,715 | $8.39 | $14.4K | 22,725,277 | SEC↗ |
| Dexcel Pharma Technologies Ltd | 10% Owner | P Buy | 2019-05-20 | 2019-05-22 | 8,285 | $7.98 | $66.1K | 22,723,562 | SEC↗ |
| Dexxon Holdings Ltd. | 10% Owner | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 22,715,277 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 22,715,277 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 22,715,277 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 22,715,277 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 22,715,277 | SEC↗ |
| SVF Investments (UK) Ltd | 10% Owner | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 22,715,277 | SEC↗ |
| HALVORSEN OLE ANDREAS | 10% Owner | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 0 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 0 | SEC↗ |
| Dexxon Holdings Ltd. | 10% Owner | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |
| Roivant Sciences Ltd. | 10% Owner | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |
| Machado Patrick | 10% Owner | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |
| QVT Associates GP LLC | 10% Owner | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |
| Lo Andrew | 10% Owner | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |
| SVF Investments (UK) Ltd | 10% Owner | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |